期刊
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
卷 1852, 期 12, 页码 2706-2711出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbadis.2015.09.022
关键词
RAGE; S100 proteins; Pancreatic ductal adenocarcinoma
资金
- Pilot Project Award at the Center for Protease Research (NIH-COBRE grant) [5P30GM103332]
- College of Health Professions at North Dakota State University
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with low survival rates. Current therapeutic treatments have very poor response rates due to the high inherent chemoresistance of the pancreatic-cancer cells. Recent studies have suggested that the receptor for advanced glycation end products (RAGE) and its S100 protein ligands play important roles in the progression of PDAC. We will discuss the potential role of S100 proteins and their receptor, RAGE, in the development and progression of pancreatic cancer. (C) 2015 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据